Lim Ju-hyun, president of Hanmi Pharm, was appointed as a director of its partner, U.S. Spectrum. Spectrum officially announced the appointment of Lim Ju-hyun, president of Hanmi Pharm, as its director on March 11, and said Lim will play a role in contributing to various cooperation between the two companies for the commercialization of new drugs currently being developed by Spectrum.
Lim, who joined Hanmi Pharm in 2007, is currently the president of Hanmi Science and Hanmi Pharm, the holding companies of Hanmi Pharm Group.
Lim is planning global strategies for various new drugs and demonstrating leadership in human resource development. She also serves as a board member of Hanmi Venture, an investment company in the healthcare sector.
President Lim said, "We are happy to be able to contribute to the Spectrum's efforts to commercialize key new drugs in the U.S. market. We will do our best to strengthen close cooperation between the two companies."
